Gene Therapy Used to Treat X-Linked SCID

A gene therapy treatment is being used to treat X-linked severe combined immunodeficiency (X-SCID).  Mustang Bio has licensed the treatment from St. Jude Children’s Research Hospital.  X-SCID is also known as “bubble boy” syndrome in which there are mutations in genes that develop immune cells.  The treatment involves giving X-SCID patients busulfan (a low dose cancer drug) before reinfusing them with their own gene modified stem cells.

Read more at the source article fiercebiotech.com

What are your thoughts about new treatments for X-SCID? Share your stories, thoughts, and hopes with the Patient Worthy community!

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email
Close Menu